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39.4
Phage Display Antibody Against Gill
Proteins of the Tropical Clam
J.-P. Gourdine1, E. J. Smith-Ravin1, and P. Greenwell2
1Biology, Universite´ des Antilles et de la Guyane, Pointe-a`-Pitre,
Guadeloupe, France; and 2University of Westminster, London,
United Kingdom
Introduction: Codakia orbicularis (Bivalvia, Lucinidae) is a tropical clam,
which lives in areas of high sulfur concentrations and which contains
endosymbiotic chemoautotrophic bacteria in its gills. Gill proteins are
thought to be involved in sulfur metabolism and in symbiont/host interac-
tions. We used the Recombinant Phage display Antibody System (RPAS)
to raise Single chain Fragment variable (ScFv) antibodies against these
proteins. Material and Methods: Griffin.1 library of phage display antibod-
ies was used. Three rounds of selection of phage panning were performed
on immunotubes coated with total extract of native gill proteins. The
bound M13 phages were isolated and tested by ELISA and the positive
clones were selected for ScFv production. The presence of ScFv DNA
inserts was assessed by PCR. These chimeric antibodies were purified by
ammonium sulfate precipitation or IMAC, and used in Dot-blot and West-
ern-blot assays as well as in plate antigen capture combined with SDS-
PAGE. Results and Discussion: Five out of 60 isolated clones were used
for ScFv production. Purification on IMAC gave ScFv antibodies of about
30 000 Daltons at a higher yield compared to ammonium sulfate precip-
itation. Antigen capture showed a strong positive reaction to a 15 000
Dalton protein, a major band in the electrophoretic profile of gill proteins.
These recombinant antibodies are being tested by immunohistochemistry
on gill sections. Total gill extract has been used for the first time to raise
phage antibodies against clam proteins, which antibodies might be useful
in the isolation and study of the properties of the said proteins.
39.5
A General Method to Design Primers for
the Amplification
E. Sosthe`ne Severin, Y Frobert, D. Boquet, C. Cre´minon,
and J. Grassi
Service de Pharmacologie et d’Immunologie, DRM/DSV,
CEA-Saclay, Gif sur Yvette, France
The great diversity of variable genes (VH and VL) of immunoglobulins
requires, for PCR amplification of these regions, the use of ”universal“
oligonucleotides primers. Nevertheless, even the most recent set of prim-
ers failed to amplify without amino acids modification the VH and VL
cDNA. We have designed a new set of mouse immunoglobulin primers
using well established criteria; i) by using the IMGT which permits to
eliminate all abnormal sequences due to a high annotation level, ii) by
designing a degenerated primer for each sub-group, iii) by designing this
degenerated primer from the alignment of DNA and cDNA. This approach
leads to a mix of primers for all sub-groups conserving the entire diversity
of amino-acids. We have successfully tested this set of primers for the
amplification of variable regions of several antibodies directed against
Histamine (mAb Hist31), Acetylcholinesterase (mAb Elec408) and prion
protein (PrP) (mAb Saf 34). We have built the recombining antibody single
chain fragment variable (ScFvHis-31) further expressed in E.coli. The
originality of our approach relies also on the use of a newly developed
prokaryotic periplasmic expression vector, including two sites of restric-
tion Sfi 1, two Tags sequences at final ends of produced ScFv. This vector
allows the fast detection of full length expressed ScFv and the corre-
sponding functional clones, using 96 wells culture plate format and the
further large-scale expression of the relevant clones in order to charac-
terize their specificity and apparent affinity.
39.6
From Genes to Intracellular Antibodies:
Dissecting the Proteome with Splint, a
Single Pot Library of Stable Antibodies
M. Visintin, I. Cannistraci, and A. Cattaneo
Lay Line Genomics, Rome, Italy
The Intracellular Antibody Capture Technology (IACT) is an in vivo two-
hybrid based method for the selection of antibodies folded for ectopic
expression (1). The IAC technology has been successfully used for the
rapid identification of antigen-antibody pairs in intracellular compartments
and for in vivo epitope mapping (2).In the original format the isolation of
intracellular antibodies or intrabodies can be done starting from existing
scFv phage display, from spleen of immunized mice or from human biopsy
of patients. To overcome the limitation of needing a purified protein
antigen for the in vitro panning step, if the phage display approach is
chosen for the construction of the IAC library, or for the immunization of
mice if the spleen RNA approach is preferred, we have constructed a
Single Pot Library of Intrabodies (SPLINT), a nave scFv yeast library from
which functional intracellular antibodies can be derived directly from gene
sequences, with no handling of proteins. In this contribution we describe
the development of SPLINT technology and the selection and character-
ization of intracellular antibodies against a panel of different antigens. The
application of SPLINT to isolate validated intrabodies on a genome-wide
scale should help the systematic study of the functional organization of the
cell proteome and should provides a valuable tool for the validation of
therapeutic targets in cell-wide analysis.
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